Nanoformulations in the Treatment of Lung Cancer: Current Status and Clinical Potential DOI
Mahmoud A. Younis,

Mohammad A. Alsogaihi,

Ahmed A. H. Abdellatif

et al.

Drug Development and Industrial Pharmacy, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 33

Published: Dec. 4, 2024

Recent developments in nanotechnology have regained the hope enabling eradication of lung cancer, while overcoming drawbacks classic therapeutics. Nevertheless, there are still formidable obstacles that hinder translation such platforms from bench into clinic. Herein, we shed light on clinical potential these formulations and discuss their future directions.

Language: Английский

Harnessing the composition of lipid nanoparticles to selectively deliver mRNA to splenic immune cells for anticancer vaccination DOI
Mahmoud A. Younis, Yusuke Sato, Yaser Hosny Ali Elewa

et al.

Drug Delivery and Translational Research, Journal Year: 2025, Volume and Issue: unknown

Published: March 7, 2025

Language: Английский

Citations

0
Nanoformulations in the Treatment of Lung Cancer: Current Status and Clinical Potential DOI
Mahmoud A. Younis,

Mohammad A. Alsogaihi,

Ahmed A. H. Abdellatif

et al.

Drug Development and Industrial Pharmacy, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 33

Published: Dec. 4, 2024

Recent developments in nanotechnology have regained the hope enabling eradication of lung cancer, while overcoming drawbacks classic therapeutics. Nevertheless, there are still formidable obstacles that hinder translation such platforms from bench into clinic. Herein, we shed light on clinical potential these formulations and discuss their future directions.

Language: Английский

Citations

2